Macrocyclic Drugs and Clinical Candidates: What Can Medicinal Chemists Learn from Their Properties?
- Authors
- Fabrizio GiordanettoJan Kihlberg
- Journal
- Journal of Medicinal Chemistry
In The Last Decade
doi.org/10.1021/jm400887j →Countries where authors are citing Macrocyclic Drugs and Clinical Candidates: What Can Medicinal Chemists Learn from Their Properties?
This map shows the geographic impact of Macrocyclic Drugs and Clinical Candidates: What Can Medicinal Chemists Learn from Their Properties?. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Macrocyclic Drugs and Clinical Candidates: What Can Medicinal Chemists Learn from Their Properties? with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Macrocyclic Drugs and Clinical Candidates: What Can Medicinal Chemists Learn from Their Properties? more than expected).
Fields of papers citing Macrocyclic Drugs and Clinical Candidates: What Can Medicinal Chemists Learn from Their Properties?
This network shows the impact of Macrocyclic Drugs and Clinical Candidates: What Can Medicinal Chemists Learn from Their Properties?. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the Macrocyclic Drugs and Clinical Candidates: What Can Medicinal Chemists Learn from Their Properties?.
About Macrocyclic Drugs and Clinical Candidates: What Can Medicinal Chemists Learn from Their Properties?
This paper, published in 2013, received 444 indexed citations . Written by Fabrizio Giordanetto and Jan Kihlberg covering the research area of Molecular Biology, Oncology and Organic Chemistry. It is primarily cited by scholars working on Molecular Biology (314 citations), Organic Chemistry (231 citations) and Computational Theory and Mathematics (82 citations). Published in Journal of Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
This paper is also available at doi.org/10.1021/jm400887j.